Fingerprint
Dive into the research topics of 'Concurrent paclitaxel-cisplatin and twice-a-day irradiation in stage IIIA and IIIB NSCLC shows improvement in local control and survival with acceptable hematologic toxicity'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically